Testosterone, sex hormone-binding globulin and the metabolic syndrome: a systematic review and meta-analysis of observational studies
Open Access
- 23 September 2010
- journal article
- research article
- Published by Oxford University Press (OUP) in International Journal of Epidemiology
- Vol. 40 (1), 189-207
- https://doi.org/10.1093/ije/dyq158
Abstract
Background Accumulating evidence suggests a sex-dependent role of circulating testosterone in the metabolic syndrome (MetS). Methods We conducted a meta-analysis of observational studies (PubMed and EMBASE—1 May 2010) relating MetS to determinants of testosterone status [total testosterone (TT), free testosterone (FT) and sex hormone-binding globulin (SHBG)]. Results A total of 52 studies were identified, comprising 22 043 men and 7839 women and presenting relative risk (RR) estimates or hormone levels for subjects with and without MetS. Endogenous TT and FT levels were lower in men with MetS [TT mean difference = −2.64 nmol/l, 95% confidence interval (CI) −2.95 to −2.32; FT standardized mean difference = −0.26 pmol/l, 95% CI −0.39 to −0.13] and higher in women with MetS (TT mean difference = 0.14 nmol/l, 95% CI 0.07–0.20; FT standardized mean difference = 0.52 pmol/l, 95% CI 0.33–0.71) compared with those without. Similarly, men with higher TT levels had a lower MetS risk (RR estimate = 0.38, 95% CI 0.28–0.50) whereas higher TT levels increased the risk of MetS in women (RR estimate = 1.68, 95% CI 1.15–2.45). In both sexes, higher SHBG levels were associated with a reduced risk (men: RR estimate = 0.29, 95% CI 0.21–0.41; women: RR estimate = 0.30, 95% CI 0.21–0.42). Conclusion This meta-analysis supports the presence of a sex-dependent association between testosterone and MetS: TT and FT levels are lower in men with MetS, whereas they are higher in women with MetS. There are no indications for a sex-specific association between SHBG and MetS. In both men and women, MetS is associated with lower SHBG levels.Keywords
This publication has 111 references indexed in Scilit:
- Genetic evidence that raised sex hormone binding globulin (SHBG) levels reduce the risk of type 2 diabetesHuman Molecular Genetics, 2009
- Sex Hormone–Binding Globulin and Risk of Type 2 Diabetes in Women and MenNew England Journal of Medicine, 2009
- Quantitative trait loci predicting circulating sex steroid hormones in men from the NCI-Breast and Prostate Cancer Cohort Consortium (BPC3)Human Molecular Genetics, 2009
- Inverse associations between muscle mass, strength, and the metabolic syndromeMetabolism, 2009
- Relative androgen excess during the menopausal transition predicts incident metabolic syndrome in midlife womenMenopause, 2009
- Menopause and the Metabolic SyndromeThe Study of Women's Health Across the NationArchives of Internal Medicine, 2008
- Association Between Hormones and Metabolic Syndrome in Older Italian MenJournal of the American Geriatrics Society, 2006
- Low sex hormone–binding globulin is associated with the metabolic syndrome in postmenopausal womenMetabolism, 2006
- Sex Differences of Endogenous Sex Hormones and Risk of Type 2 DiabetesJAMA, 2006
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986